Concepedia

Joseph Quintavalla

JQ

Statistics

Publications

9

Citations

581

H-Index

9

Active since

1979

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

New York University

Joseph Quintavalla is an author at Novartis (Switzerland) specializing in medicine, osteoarthritis, and life sciences.

Publications per year

1979–2005

9

Publications

9

Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects

Joseph Quintavalla, Susan Uziel‐Fusi, Jianyun Yin et al. · Biomaterials · 2002 · 128 citations

Medicine, Cell Biology, Orthopedic Surgery +14

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2

Ronald E. Esser, Carol Berry, Zhengming Du et al. · British Journal of Pharmacology · 2005 · 123 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Decrease in mouse lung and liver glutathione peroxidase activity and potentiation of the lethal effects of ozone and paraquat by the superoxide dismutase inhibitor diethyldithio-carbamate

Bernard D. Goldstein, Michael G. Rozen, Joseph Quintavalla et al. · Biochemical Pharmacology · 1979 · 95 citations

Life Sciences, Biochemistry, Toxicology +17

A new model of osteoarthritis in rabbits

Megan Butler, Claudio Colombo, Leaden Hickman et al. · Arthritis & Rheumatism · 1983 · 56 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Development of comprehensive functional genomic screens to identify novel mediators of osteoarthritis

Sherif Daouti, Brian Latario, Sujatha Nagulapalli et al. · Osteoarthritis and Cartilage · 2005 · 48 citations

Life Sciences, Genetics, Molecular Biology +11

1–5 of 9